AHCL Share Price | Anlon Healthcare Ltd Stock Analysis & Recommendation

Q: Why is Anlon Healthcare Ltd falling/rising?

As of 16-Mar, Anlon Healthcare Ltd's stock price is falling, currently at 115.50, which reflects a decrease of 0.8 or 0.69%. The stock has been on a downward trend, having lost value for the last three consecutive days, resulting in a total decline of 9.27% during this period. Additionally, the stock has underperformed compared to the benchmark Sensex, which has only decreased by 2.66% over the same week.Further analysis reveals that Anlon Healthcare's performance over various time frames has also been negative, with a year-to-date decline of 23.69%, significantly worse than the Sensex's decline of 11.40%. The stock is currently trading below its moving averages across all time frames, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, indicating a persistent downward trend.Investor participation has also decreased, as evidenced by a delivery volume of 1.43 lacs on 13 March, which is down by 58.81% compared to the 5-day average. This drop in trading activity suggests a lack of confidence among investors, contributing to the stock's decline. Overall, these factors collectively explain why Anlon Healthcare Ltd's stock price is falling.

Technical Trend Update: Anlon Healthcare witnessed a change in Technical Grade on 23 Mar 2026. Click here to discover latest technical change!

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

2.39 lacs (13.56%) Volume

Shareholding (Dec 2025)

FII

0.23%

Held by 4 FIIs

DII

4.40%

Held by 1 DIIs

Promoter

52.68%

When is the next results date for Anlon Healthcare Ltd?

04-Feb-2026

The next results date for Anlon Healthcare Ltd is 09 February 2026.

View full answer

Why is Anlon Healthcare Ltd falling/rising?

17-Mar-2026

As of 16-Mar, Anlon Healthcare Ltd's stock price is declining, currently at 115.50, reflecting a 0.69% decrease. The stock has lost 9.27% over the last three days and has underperformed compared to the Sensex, with a year-to-date decline of 23.69%.

View full answer

Which are the latest news on Anlon Healthcare?

25-Mar-2026

When is the next results date for Anlon Healthcare Ltd?

Compare Anlon Healthcare with Similar Stocks

Themis Medicare Shree Ganesh Rem Bharat Parenter.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

Unrated Stock - No Analysis Available

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

INR 612 Cr (Micro Cap)

P/E

40.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

0.07

Return on Equity

9.57%

Price to Book

2.76

Revenue and Profits:

Net Sales:

36 Cr

(Quarterly Results - Dec 2025)

Net Profit:

5 Cr

Total Returns

Total Returns (Price + Dividend)

Dividend Yield (0%)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-17.14%

6 Months

-13.48%

1 Year

0.0%

2 Years

0.0%

3 Years

0.0%

4 Years

0.0%

5 Years

0.0%

Anlon Healthcare for the last several years.

Risk Adjusted Returns v/s

Returns Beta

Beta has not been calculated since enough price history is not available

News & Corporate Actions

News

When is the next results date for Anlon Healthcare Ltd?

The next results date for Anlon Healthcare Ltd is scheduled for 09 February 2026....

Read full news article

Announcements

Announcement under Regulation 30 (LODR)-Updates on Acquisition

20-Mar-2026 | Source : BSE

We have attached herewith intimation as per Regulation 30 of SEBI (LODR) Regulation 2015 regarding acquisition of stake in Bizotic Life Science Private Limited. Kindly take the same on your record. Thank you.

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

18-Mar-2026 | Source : BSE

We have attached herewith Intimation of investor meet will be held on Saturday March 21 2026. Kindly take the same on your record. Thank you.

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011

12-Mar-2026 | Source : BSE

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Neomile Growth Fund - Series I

Corporate Actions

BOARD MEETING

No Upcoming Board Meetings

DIVIDEND

No Dividend history available

SPLITS

No Splits history available

BONUS

No Bonus history available

RIGHTS

No Rights history available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

65.60%

EBIT Growth (5y)

58.45%

EBIT to Interest (avg)

8.18

Debt to EBITDA (avg)

2.57

Net Debt to Equity (avg)

0.70

Sales to Capital Employed (avg)

0.86

Tax Ratio

23.69%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

4.72%

ROCE (avg)

9.07%

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

2.88

EV to EBIT

20.73

EV to EBITDA

19.59

EV to Capital Employed

2.76

EV to Sales

5.25

PEG Ratio

Dividend Yield

ROCE (Latest)

13.30%

ROE (Latest)

9.57%

Technicals key factors

Indicator

Weekly

Monthly

MACD

RSI

No Signal

Bollinger Bands

Bearish

KST

Dow Theory

Mildly Bearish

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Dec 2025

Shareholding Compare (%holding)

Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 4 FIIs (0.23%)

Promoter with highest holding

Punitkumar R Rasadia (34.98%)

Highest Public shareholder

Shree Dwarikadhish Ventures Llp (7.53%)

Individual Investors Holdings

23.58%

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Dec'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is -31.84% vs 56.76% in Sep 2025",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is -44.74% vs 162.54% in Sep 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "35.58",
          "val2": "52.20",
          "chgp": "-31.84%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "12.34",
          "val2": "13.73",
          "chgp": "-10.12%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "1.58",
          "val2": "0.87",
          "chgp": "81.61%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "5.15",
          "val2": "9.32",
          "chgp": "-44.74%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "34.68%",
          "val2": "26.30%",
          "chgp": "8.38%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "85.50",
          "val2": "62.00",
          "chgp": "37.90%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "19.98",
          "val2": "14.45",
          "chgp": "38.27%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.68",
          "val2": "1.91",
          "chgp": "-12.04%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "12.86",
          "val2": "6.36",
          "chgp": "102.20%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "23.37%",
          "val2": "23.31%",
          "chgp": "0.06%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "121.08",
          "val2": "71.36",
          "chgp": "69.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "32.32",
          "val2": "15.03",
          "chgp": "115.04%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "3.26",
          "val2": "2.80",
          "chgp": "16.43%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "18.01",
          "val2": "3.87",
          "chgp": "365.37%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "26.69%",
          "val2": "21.06%",
          "chgp": "5.63%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "120.29",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "32.21",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Interest",
          "val1": "3.72",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "20.52",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "26.78%",
          "val2": "NA%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Standalone) - Dec'25 - QoQ

Dec'25

Sep'25

Change(%)

Net Sales

35.58

52.20

-31.84%

Operating Profit (PBDIT) excl Other Income

12.34

13.73

-10.12%

Interest

1.58

0.87

81.61%

Exceptional Items

0.00

Standalone Net Profit

5.15

9.32

-44.74%

Operating Profit Margin (Excl OI)

34.68%

26.30%

8.38%

Values in Rs Cr.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Dec 2025 is -31.84% vs 56.76% in Sep 2025

Standalone Net Profit

QoQ Growth in quarter ended Dec 2025 is -44.74% vs 162.54% in Sep 2025

All Quarterly Results

Half Yearly Results Snapshot (Standalone) - Sep'25

Sep'25

Sep'24

Change(%)

Net Sales

85.50

62.00

37.90%

Operating Profit (PBDIT) excl Other Income

19.98

14.45

38.27%

Interest

1.68

1.91

-12.04%

Exceptional Items

0.00

Standalone Net Profit

12.86

6.36

102.20%

Operating Profit Margin (Excl OI)

23.37%

23.31%

0.06%

Values in Rs Cr.

Compare with Peers

Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

All Half Yearly Results

Nine Monthly Results Snapshot (Standalone) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

121.08

71.36

69.67%

Operating Profit (PBDIT) excl Other Income

32.32

15.03

115.04%

Interest

3.26

2.80

16.43%

Exceptional Items

0.00

Standalone Net Profit

18.01

3.87

365.37%

Operating Profit Margin (Excl OI)

26.69%

21.06%

5.63%

Values in Rs Cr.

Compare with Peers

Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

All Nine Monthly Results

Annual Results Snapshot (Standalone) - Mar'25

Mar'25

Change(%)

Net Sales

120.29

Operating Profit (PBDIT) excl Other Income

32.21

Interest

3.72

Exceptional Items

0.00

Standalone Net Profit

20.52

Operating Profit Margin (Excl OI)

26.78%

NA%

Values in Rs Cr.

Compare with Peers

Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

All Annual Results

Company CV

About Anlon Healthcare Ltd

Anlon Healthcare Ltd

Micro Cap

Pharmaceuticals & Biotechnology

No Details Available.

Company Coordinates

No Company Details Available